METRONIDAZOLE | N216755 | SAPTALIS PHARMACEUTICALS LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
SAPTALIS PHARMACEUTICALS, LLC et al v. MSN PHARMACEUTICALS, INC. et al 2 patentsANDA 221087metronidazole | D.N.J. | 2026-02-03 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Upadhye Tang LLP on behalf of Saptalis Pharmaceuticals,... FDA-2026-P-7928 · 2 docket documents Upadhye Tang LLP filed this citizen petition on behalf of Saptalis Pharmaceuticals, LLC regarding an unspecified drug or product, but the provided text does not contain detailed information about the specific drug name, the requested regulatory action, or the particular mechanism such as 505(q), AND | Other | 2026-07-23 | Open | Saptalis Pharmaceuticals, LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$2.61
per ml
Lowest NADAC/Unit
$2.60
per ml
Brand NDCs
2
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 71656006620LIKMEZ 500 MG/5 ML SUSPENSION | $2.61 | ML | Brand | — | 2026-08-19 |
| 71656006675LIKMEZ 500 MG/5 ML SUSPENSION | $2.60 | ML | Brand | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.